Fibroids

Preliminary data reported from European gynecology anti-adhesion study

Published in Biotech Business Week, December 20th, 2004

Angiotech Pharmaceuticals, Inc., (ANPI, ANP) announced preliminary 8-week follow-up data on 20 patients from a single center in its pivotal European study using Adhibit to reduce the incidence and severity of adhesions following laparoscopic surgery in a gynecological population.

Data from this pivotal trial may be used to support the European submission for consideration of CE Mark approval and commercialization in Europe. The results were announced at the 33rd annual meeting of the American Association of Gynecologic Laparoscopists in San Francisco, California.

The study involves 75 patients in total - randomized 2:1, and was initiated at four...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-12-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry